Dr. Anne Kathryn Schuckman, MD

Dr. Schuckman practices at Urology - Nch Urology - HOPD in Los Angeles, California.

Dr. Schuckman's NPI, 1871645911, was assigned on January 17, 2007. Dr. Schuckman graduated from Keck School of Medicine of USC in 2000. Dr. Schuckman's California license number on file is A77646.

Dr. Schuckman's primary practice is Urology - Nch Urology - HOPD, at 1516 San Pablo St, Los Angeles, CA 90033.

Dr. Schuckman's primary practice is Urology - Nch Urology - HOPD in Los Angeles, California. Dr. Schuckman is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Schuckman to 3 more hospitals, 2 hospital outpatient departments, 1 group practice or clinic, 1 home health agency, 1 other site, 1 rural health clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schuckman practices, 11 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Schuckman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Schuckman is board certified in urology by the American Board of Urology. Dr. Schuckman has a license on file in California.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and pelvic prolapse among the conditions Dr. Schuckman treats.

CMS data shows 581 Medicare services from Dr. Schuckman across 6 procedure codes in 2024, for 316 Medicare patients. Medicare paid $39,288 for them.

CMS counts 316 Medicare patients who saw Dr. Schuckman in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schuckman's median patient age at 71, with 26% women.

In 2024, Dr. Schuckman wrote 211 Medicare Part D claims for 64 patients. 94% of them were for generic drugs. CMS names the drug for 151 of them, across 4 drugs with 11 or more claims each, at $2,329 in total drug cost. In 2023, CMS named 163 claims across 6 drugs.

Dr. Schuckman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schuckman as offering telehealth. CMS counts 16 procedures of prostate resection by Dr. Schuckman, more than 74% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Schuckman, published from 2016 to 2020. Dr. Schuckman's most frequent co-authors are Siamak Daneshmand, MD, Hooman Djaladat, MD and Soroush Bazargani, MD.

Dmand AI links Dr. Schuckman to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Non-Muscle Invasive Bladder Neoplasms, Penile Neoplasms and Carcinoma in Situ.

CMS Open Payments shows 88 general payments to Dr. Schuckman from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Photocure Inc paid the most, $8,698.

Dmand AI lists 1 award for Dr. Schuckman. Dr. Schuckman serves on ASCO evidence based medicine committee.

Dr. Schuckman graduated from Keck School of Medicine of USC in 2000.

Dr. Schuckman is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.